What is Cimpress' operating income?

Cimpress' total operating income in 2026 was $251.03 million, based on the following breakdown: Total Gross Profit: $1.73 billion Total Operating Expenses: $1.48 billion

Cimpress (CMPR) Financials

$91.22 -3.24 (-3.43%)

As of 01:25 PM Eastern

Compare

Annual Income Statements for Cimpress

This table shows Cimpress' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	54	-72	44	95	83	-85	-54	-186	174	15	96
Consolidated Net Income / (Loss)	50	-72	47	93	84	-82	-51	-186	178	13	97
Net Income / (Loss) Continuing Operations	50	-72	47	93	185	-82	-51	-186	178	13	97
Total Pre-Tax Income	66	-79	66	127	3.00	-64	9.33	-30	128	97	153
Total Operating Income	78	-46	158	164	56	124	47	57	247	226	251
Total Gross Profit	1,014	1,098	1,313	1,350	1,232	1,276	1,395	1,439	1,597	1,617	1,730
Total Revenue	1,788	2,135	2,593	2,751	2,481	2,576	2,888	3,080	3,292	3,403	3,737
Operating Revenue	1,788	2,135	2,593	2,751	2,481	2,576	2,888	3,080	3,292	3,403	3,737
Total Cost of Revenue	774	1,037	1,280	1,401	1,249	1,300	1,493	1,641	1,695	1,786	2,007
Operating Cost of Revenue	774	1,037	1,280	1,401	1,249	1,300	1,493	1,641	1,695	1,786	2,007
Total Operating Expenses	936	1,144	1,155	1,186	1,076	1,153	1,348	1,382	1,349	1,391	1,479
Selling, General & Admin Expense	146	208	177	163	183	196	197	209	206	219	235
Marketing Expense	509	611	715	714	574	648	789	774	790	814	871
Research & Development Expense	210	243	246	237	253	253	293	302	322	334	353
Amortization Expense	41	46	50	53	52	54	54	47	31	19	14
Impairment Charge	31	9.56	0.00	7.50	-	0.00	0.00	5.61	0.00	0.00	0.00
Restructuring Charge	0.38	27	15	12	14	1.64	14	44	0.42	5.53	6.26
Total Other Income / (Expense), net	-12	-34	-91	-37	-53	-187	-38	-88	-119	-129	-98
Interest Expense	38	44	70	63	76	168	99	106	120	116	109
Other Income / (Expense), net	26	10	-21	26	23	-19	61	18	1.58	-14	11
Income Tax Expense	16	-7.12	20	33	-81	19	60	155	-49	84	56
Net Income / (Loss) Attributable to Noncontrolling Interest	-3.94	-0.49	3.06	-1.57	0.63	2.77	3.76	0.26	4.13	-2.10	1.24
Basic Earnings per Share	$1.72	($2.29)	$1.41	$3.09	$3.07	($3.28)	($2.08)	($7.08)	$6.64	$0.60	$3.93
Weighted Average Basic Shares Outstanding	31.66M	31.29M	30.95M	30.79M	27.18M	26.00M	26.09M	26.25M	26.15M	24.92M	24.43M
Diluted Earnings per Share	$1.64	($2.29)	$1.36	$3.00	$3.00	$0.00	($2.08)	($7.08)	$6.43	$0.58	$3.79
Weighted Average Diluted Shares Outstanding	33.05M	31.29M	32.22M	31.66M	27.77M	0.00	26.09M	26.25M	27.00M	25.64M	25.33M
Weighted Average Basic & Diluted Shares Outstanding	31.60M	31.30M	31M	30.80M	25.89M	25.05M	26.14M	26.36M	25.07M	24.48M	24.35M

This table shows Cimpress' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Income / (Loss) Attributable to Common Shareholders	58	-3.98	115	-13	61	-8.24	-25	7.64	49	14	25
Consolidated Net Income / (Loss)	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15	26
Net Income / (Loss) Continuing Operations	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15	26
Total Pre-Tax Income	77	5.43	33	-3.39	83	4.12	13	24	63	26	39
Total Operating Income	108	39	66	39	81	41	65	49	88	49	65
Total Gross Profit	458	376	404	382	450	373	413	403	488	409	430
Total Revenue	921	781	833	805	939	789	869	863	1,042	886	945
Operating Revenue	921	781	833	805	939	789	869	863	1,042	886	945
Total Cost of Revenue	463	405	428	423	489	417	457	460	554	477	515
Operating Cost of Revenue	463	405	428	423	489	417	457	460	554	477	515
Total Operating Expenses	350	337	338	343	369	332	347	354	400	360	365
Selling, General & Admin Expense	49	54	54	52	57	51	59	54	60	59	62
Marketing Expense	212	192	194	204	224	193	193	210	246	209	206
Research & Development Expense	80	84	84	82	83	83	86	85	89	87	92
Amortization Expense	9.18	6.92	5.46	5.16	5.12	4.52	4.27	4.25	2.88	2.89	3.77
Restructuring Charge	0.48	0.13	0.15	0.10	0.16	0.47	4.80	0.30	1.31	2.81	1.85
Total Other Income / (Expense), net	-31	-34	-33	-43	1.82	-36	-52	-25	-25	-23	-25
Interest Expense	30	30	32	31	30	27	28	28	27	25	29
Other Income / (Expense), net	-0.39	-3.65	-0.79	-11	32	-9.44	-24	3.45	1.73	2.58	3.58
Income Tax Expense	17	11	-85	9.00	21	12	42	18	13	12	13
Net Income / (Loss) Attributable to Noncontrolling Interest	2.15	-1.20	3.17	0.17	0.56	0.22	-3.04	-1.12	0.15	0.80	1.41
Basic Earnings per Share	$2.18	($0.15)	$4.44	($0.50)	$2.45	($0.33)	($1.02)	$0.31	$2.01	$0.57	$1.04
Weighted Average Basic Shares Outstanding	26.61M	26.22M	26.15M	25.17M	24.97M	24.83M	24.92M	24.57M	24.57M	24.26M	24.43M
Diluted Earnings per Share	$2.14	($0.15)	$4.27	($0.50)	$2.36	($0.33)	($0.95)	$0.30	$1.95	$0.55	$0.99
Weighted Average Diluted Shares Outstanding	27.18M	26.22M	27.00M	25.17M	25.91M	24.83M	25.64M	25.05M	25.30M	25.19M	25.33M
Weighted Average Basic & Diluted Shares Outstanding	26.64M	25.45M	25.07M	25.15M	24.82M	24.88M	24.48M	24.67M	24.29M	24.23M	24.35M

This table details how cash moves in and out of Cimpress' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Net Change in Cash & Equivalents	-26	-52	-76	-8.95	9.74	128	234	-151	73	30	15
Net Cash From Operating Activities	247	157	192	331	338	265	220	130	351	298	284
Net Cash From Continuing Operating Activities	247	157	192	331	316	251	220	130	350	298	283
Net Income / (Loss) Continuing Operations	50	-72	47	93	84	-82	-51	-186	178	13	97
Consolidated Net Income / (Loss)	50	-72	47	93	84	-82	-51	-186	178	13	97
Depreciation Expense	132	158	169	174	168	173	176	162	152	141	152
Non-Cash Adjustments To Reconcile Net Income	42	56	24	29	131	98	37	42	67	45	77
Changes in Operating Assets and Liabilities, net	23	15	-48	35	-67	62	58	111	-47	99	-43
Net Cash From Investing Activities	-266	-302	-11	-420	-67	-354	-4.00	-104	-55	-141	-196
Net Cash From Continuing Investing Activities	-266	-302	-11	-420	-67	-354	136	-104	-55	-141	-196
Purchase of Property, Plant & Equipment	-107	-111	-102	-119	-94	-99	-126	-112	-113	-153	-167
Acquisitions	-165	-205	-0.42	-290	-4.27	-53	75	-0.50	-3.62	-0.66	-32
Purchase of Investments	-	-	-	-12	30	-207	0.00	-84	0.00	5.44	0.00
Sale of Property, Plant & Equipment	0.00	4.51	0.89	0.64	1.64	5.70	38	4.66	24	3.08	6.02
Divestitures	0.00	0.00	94	0.00	-1.12	0.00	0.00	-4.13	0.00	0.00	0.00
Sale and/or Maturity of Investments	-	6.35	0.00	-	0.00	0.00	149	92	39	4.50	0.00
Other Investing Activities, net	6.11	3.89	-3.06	0.35	1.56	-0.27	0.62	-0.28	0.00	0.00	-1.90
Net Cash From Financing Activities	-5.34	105	-178	82	-258	224	-107	-177	-223	-136	-68
Net Cash From Continuing Financing Activities	-5.34	105	-249	82	-258	229	-107	-177	-223	-136	-68
Repayment of Debt	-445	-556	-1,313	-967	-1,362	-1,564	-16	-107	-246	-592	-129
Repurchase of Common Equity	-153	-50	-96	-141	-627	-5.06	-2.17	-96	-157	-82	-75
Payment of Dividends	5.14	0.00	0.00	-3.38	-3.96	-4.75	-3.96	-3.65	-0.55	-0.82	0.00
Issuance of Debt	598	738	1,206	1,143	1,764	1,815	0.00	48	206	567	139
Issuance of Common Equity	4.71	6.19	12	60	22	2.28	0.00	0.33	2.10	1.38	28
Other Financing Activities, net	-15	-34	14	-9.26	-52	-15	-84	-20	-27	-30	-31
Effect of Exchange Rate Changes	-2.64	0.79	2.51	-1.87	-	2.97	-15	-	-0.09	8.82	-5.25
Other Net Changes in Cash	0.00	-12	12	0.00	-3.58	-	0.00	0.00	0.00	0.00	0.00
Cash Interest Paid	38	45	57	64	73	117	98	114	132	110	110
Cash Income Taxes Paid	20	49	32	26	14	28	33	31	49	33	59

This table details how cash moves in and out of Cimpress' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
Net Change in Cash & Equivalents	148	-120	49	-51	71	-41	51	-33	58	-69	60
Net Cash From Operating Activities	175	8.43	125	4.38	177	9.70	107	25	165	-17	111
Net Cash From Continuing Operating Activities	177	8.43	125	4.64	176	9.70	107	25	165	-17	110
Net Income / (Loss) Continuing Operations	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15	26
Consolidated Net Income / (Loss)	60	-5.18	118	-12	62	-8.02	-28	6.52	49	15	26
Depreciation Expense	39	37	36	36	35	34	36	37	37	37	41
Non-Cash Adjustments To Reconcile Net Income	13	31	20	6.59	17	12	8.36	15	20	23	18
Changes in Operating Assets and Liabilities, net	64	-54	-49	-25	62	-29	91	-33	58	-92	24
Net Cash From Investing Activities	-20	-14	-9.91	-26	-38	-41	-37	-43	-51	-39	-63
Net Cash From Continuing Investing Activities	-20	-14	-9.91	-26	-38	-41	-37	-43	-51	-39	-63
Purchase of Property, Plant & Equipment	-25	-26	-25	-32	-43	-41	-37	-44	-41	-40	-43
Acquisitions	-	-	-3.62	0.00	-	-0.66	-	0.00	-10	-1.30	-21
Sale of Property, Plant & Equipment	0.35	0.43	17	1.57	0.10	0.69	0.72	0.82	0.87	1.70	2.63
Other Investing Activities, net	-	-	-	0.00	-	-	-	0.00	-	0.10	-2.00
Net Cash From Financing Activities	-12	-110	-65	-35	-59	-13	-29	-15	-57	-8.92	13
Net Cash From Continuing Financing Activities	-12	-110	-65	-35	-59	-13	-29	-15	-57	-8.92	13
Repayment of Debt	-8.55	-4.11	-210	-535	-48	-4.61	-4.14	-3.92	-4.37	-5.44	-116
Issuance of Debt	0.35	0.37	205	525	41	0.09	0.44	0.18	0.97	2.35	136
Issuance of Common Equity	0.01	0.69	1.33	1.00	0.37	0.01	-	0.51	0.78	25	1.23
Other Financing Activities, net	-3.90	-6.50	-4.99	-15	-6.03	-4.88	-3.96	-8.70	-6.25	-7.16	-8.93
Effect of Exchange Rate Changes	-	-3.63	-0.71	5.71	-8.82	3.31	8.61	-1.06	0.57	-4.30	-0.46
Cash Interest Paid	42	24	42	35	20	36	19	37	19	35	18
Cash Income Taxes Paid	11	13	10	1.83	13	9.62	12	13	8.82	14	23

This table presents Cimpress' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
Total Assets	1,464	1,680	1,652	1,868	1,815	2,182	2,168	1,855	1,892	1,968	2,203
Total Current Assets	201	246	239	240	248	528	626	441	458	503	564
Cash & Equivalents	77	26	44	35	45	183	277	130	204	234	249
Short-Term Investments	7.89	-	-	-	0.00	152	50	39	4.50	0.00	0.00
Accounts Receivable	32	49	56	61	35	51	64	67	65	68	74
Inventories, net	18	47	61	66	80	70	127	108	97	113	137
Prepaid Expenses	65	79	79	78	89	73	109	97	88	87	105
Plant, Property, & Equipment, net	493	512	484	491	339	329	287	288	265	302	367
Total Noncurrent Assets	770	922	929	1,137	1,228	1,325	1,255	1,126	1,169	1,163	1,271
Long-Term Investments	-	-	-	-	0.00	51	0.00	4.50	0.00	0.00	0.00
Goodwill	466	515	521	719	622	727	767	782	787	826	851
Intangible Assets	252	324	286	333	281	274	245	205	169	163	177
Noncurrent Deferred & Refundable Income Taxes	26	48	67	60	143	150	113	13	95	61	51
Other Noncurrent Operating Assets	26	35	55	26	182	124	130	123	118	113	192
Total Liabilities & Shareholders' Equity	1,464	1,680	1,652	1,868	1,815	2,182	2,168	1,855	1,892	1,968	2,203
Total Liabilities	1,232	1,559	1,472	1,673	2,153	2,561	2,531	2,467	2,419	2,532	2,601
Total Current Liabilities	336	449	481	521	487	638	693	645	664	759	776
Short-Term Debt	22	29	59	81	18	9.90	10	11	12	9.09	15
Accounts Payable	87	127	152	185	164	200	314	286	327	332	333
Accrued Expenses	179	176	187	195	211	248	254	257	246	304	325
Current Deferred Revenue	26	30	28	32	39	51	59	45	46	48	49
Other Current Liabilities	23	78	55	28	55	130	56	47	33	65	54
Total Noncurrent Liabilities	897	1,110	991	1,153	1,667	1,923	1,839	1,821	1,755	1,773	1,825
Long-Term Debt	657	848	768	942	1,416	1,733	1,676	1,627	1,592	1,576	1,597
Noncurrent Deferred & Payable Income Tax Liabilities	69	61	51	45	34	27	41	47	25	23	24
Other Noncurrent Operating Liabilities	170	201	172	166	217	163	122	147	138	173	203
Redeemable Noncontrolling Interest	65	45	86	63	69	71	131	11	23	19	76
Total Equity & Noncontrolling Interests	166	75	94	132	-407	-449	-495	-623	-550	-583	-474
Total Preferred & Common Equity	166	75	94	132	407	-449	-495	-623	-550	-583	-494
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	166	75	94	132	-407	-449	-495	-623	-550	-583	-494
Common Stock	336	362	396	412	-439	461	502	540	571	593	624
Retained Earnings	486	415	453	537	-618	530	414	235	273	225	279
Treasury Stock	-549	-588	-686	-737	1,376	-1,369	-1,364	-1,364	-1,364	-1,364	-1,364
Accumulated Other Comprehensive Income / (Loss)	-108	-113	-70	-80	89	-71	-47	-35	-30	-38	-34
Noncontrolling Interest	0.35	0.21	0.29	-	-	-	0.00	0.46	0.63	0.99	20

This table presents Cimpress' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	12/31/2022	3/31/2023	9/30/2023	12/31/2023	3/31/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	1,952	1,893	1,809	1,948	1,784	1,884	1,918	1,878	1,967	2,094	2,055
Total Current Assets	525	470	444	578	442	428	496	444	489	561	496
Cash & Equivalents	111	115	125	274	154	153	224	183	201	258	189
Short-Term Investments	85	68	23	17	6.50	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Receivable	70	68	69	63	71	74	59	66	79	71	73
Inventories, net	141	116	114	105	96	110	103	102	119	123	124
Prepaid Expenses	118	103	113	119	114	91	109	93	91	110	110
Plant, Property, & Equipment, net	278	284	272	277	270	274	279	288	315	349	353
Total Noncurrent Assets	1,148	1,139	1,094	1,093	1,072	1,182	1,144	1,147	1,162	1,185	1,206
Long-Term Investments	17	6.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	777	787	772	791	779	805	778	793	826	827	818
Intangible Assets	225	215	191	188	176	169	158	158	161	162	158
Noncurrent Deferred & Refundable Income Taxes	9.52	10	12	12	9.44	97	90	88	58	57	55
Other Noncurrent Operating Assets	120	120	118	102	107	111	118	108	117	139	174
Total Liabilities & Shareholders' Equity	1,952	1,893	1,809	1,948	1,784	1,884	1,918	1,878	1,967	2,094	2,055
Total Liabilities	2,553	2,543	2,412	2,487	2,408	2,430	2,453	2,415	2,519	2,618	2,509
Total Current Liabilities	697	676	639	708	636	670	728	680	755	826	730
Short-Term Debt	10	11	11	11	11	11	9.63	9.18	8.98	14	14
Accounts Payable	319	264	264	344	269	298	341	299	318	354	308
Accrued Expenses	265	300	273	265	271	267	285	273	308	353	303
Current Deferred Revenue	49	55	49	45	50	52	48	53	57	50	54
Other Current Liabilities	55	46	42	42	35	43	44	45	62	56	51
Total Noncurrent Liabilities	1,856	1,868	1,773	1,779	1,772	1,760	1,725	1,735	1,764	1,792	1,779
Long-Term Debt	1,679	1,683	1,595	1,601	1,591	1,586	1,579	1,578	1,574	1,578	1,575
Noncurrent Deferred & Payable Income Tax Liabilities	47	44	49	45	47	24	23	21	23	23	22
Other Noncurrent Operating Liabilities	130	141	129	133	134	151	123	136	167	192	182
Redeemable Noncontrolling Interest	13	12	11	13	12	24	19	20	18	6.06	70
Total Equity & Noncontrolling Interests	-613	-662	-614	-552	-635	-570	-554	-557	-571	-530	-524
Total Preferred & Common Equity	-613	-662	-614	-553	-636	-571	-554	-558	-571	-531	-524
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-613	-662	-614	-553	-636	-571	-554	-558	-571	-531	-524
Common Stock	522	530	544	561	563	574	577	586	601	609	613
Retained Earnings	256	207	240	298	206	251	278	266	231	261	256
Treasury Stock	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364	-1,364
Accumulated Other Comprehensive Income / (Loss)	-28	-35	-35	-47	-41	-32	-46	-46	-39	-37	-30
Noncontrolling Interest	-	0.54	0.56	0.63	0.62	0.73	0.78	0.94	0.56	0.70	0.00

This table displays calculated financial ratios and metrics derived from Cimpress' official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	24,232,090.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	24,232,090.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	3.96
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.67%	19.43%	21.41%	6.12%	-9.80%	3.81%	12.10%	6.65%	6.89%	3.38%	9.80%
EBITDA Growth	10.40%	-47.90%	148.47%	18.99%	-32.17%	12.39%	2.55%	-16.24%	68.19%	-11.70%	17.07%
EBIT Growth	-10.45%	-133.89%	487.01%	38.98%	-58.52%	32.11%	4.42%	-30.30%	228.38%	-14.56%	23.36%
NOPAT Growth	-30.85%	-153.64%	447.75%	8.32%	1,199.06%	-94.48%	-396.49%	115.65%	753.54%	-91.24%	431.62%
Net Income Growth	-43.56%	-243.22%	164.80%	99.79%	-10.15%	-198.17%	38.67%	-267.24%	195.74%	-92.77%	655.63%
EPS Growth	-39.93%	-239.63%	159.39%	120.59%	0.00%	-100.00%	0.00%	-240.38%	190.82%	-90.98%	553.45%
Operating Cash Flow Growth	2.20%	-36.64%	22.71%	72.15%	2.22%	-21.64%	-17.23%	-40.65%	169.19%	-15.01%	-4.82%
Free Cash Flow Firm Growth	-488.43%	-161.25%	158.39%	-221.08%	1,797.56%	-90.67%	-272.68%	166.80%	78.17%	-65.72%	-115.74%
Invested Capital Growth	16.01%	13.28%	3.06%	22.91%	-11.25%	-6.86%	1.77%	-14.33%	1.96%	-9.39%	22.47%
Revenue Q/Q Growth	5.84%	4.15%	2.65%	1.61%	-9.01%	8.70%	3.13%	2.19%	1.35%	1.10%	2.06%
EBITDA Q/Q Growth	18.43%	-28.11%	18.08%	10.43%	-22.35%	7.23%	-4.09%	36.45%	-0.17%	-6.36%	8.48%
EBIT Q/Q Growth	38.72%	-276.81%	53.30%	20.27%	-46.32%	17.36%	-8.34%	605.58%	1.85%	-10.30%	11.59%
NOPAT Q/Q Growth	7.65%	-128.33%	87.33%	27.26%	646.98%	11.06%	-538.50%	341.09%	124.57%	-90.33%	90.23%
Net Income Q/Q Growth	77.82%	-251.90%	161.18%	71.06%	-47.57%	-42.11%	41.29%	24.19%	104.33%	-91.94%	129.62%
EPS Q/Q Growth	69.07%	-236.76%	161.54%	77.51%	-43.40%	100.00%	-182.87%	29.27%	-37.87%	-90.00%	104.86%
Operating Cash Flow Q/Q Growth	1.03%	-10.84%	8.22%	22.55%	-13.81%	-2.97%	23.34%	-16.64%	22.01%	-5.58%	1.08%
Free Cash Flow Firm Q/Q Growth	77.25%	10.96%	-8.76%	42.28%	442.55%	-28.66%	-266.49%	-19.52%	72.66%	-57.06%	-430.94%
Invested Capital Q/Q Growth	-0.70%	-4.23%	1.97%	-2.38%	-5.27%	1.43%	-9.29%	-0.10%	6.36%	-9.19%	1.99%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.73%	51.44%	50.64%	49.06%	49.67%	49.54%	48.30%	46.73%	48.51%	47.53%	46.29%
EBITDA Margin	13.21%	5.76%	11.79%	13.23%	9.95%	10.77%	9.85%	7.74%	12.17%	10.40%	11.08%
Operating Margin	4.37%	-2.14%	6.09%	5.95%	2.26%	4.79%	1.64%	1.86%	7.51%	6.65%	6.72%
EBIT Margin	5.83%	-1.66%	5.28%	6.91%	3.18%	4.04%	3.77%	2.46%	7.56%	6.25%	7.02%
Profit (Net Income) Margin	2.82%	-3.38%	1.80%	3.40%	3.39%	-3.20%	-1.75%	-6.03%	5.40%	0.38%	2.60%
Tax Burden Percent	76.27%	91.03%	70.50%	73.66%	2,797.04%	129.74%	-541.96%	614.50%	138.43%	13.26%	63.52%
Interest Burden Percent	63.38%	224.44%	48.52%	66.77%	3.81%	-61.02%	8.58%	-39.87%	51.60%	45.59%	58.27%
Effective Tax Rate	23.73%	0.00%	29.50%	26.34%	-2,697.04%	0.00%	641.96%	0.00%	-38.43%	86.74%	36.48%
Return on Invested Capital (ROIC)	7.77%	-3.64%	11.73%	11.23%	140.18%	8.52%	-25.98%	4.34%	39.76%	3.62%	18.19%
ROIC Less NNEP Spread (ROIC-NNEP)	5.92%	-9.35%	3.65%	8.18%	15.52%	-3.78%	-10.82%	-11.66%	28.25%	2.37%	13.60%
Return on Net Nonoperating Assets (RNNOA)	10.95%	-37.38%	19.39%	38.61%	-257.35%	14.49%	39.61%	33.75%	-71.00%	-5.98%	-38.39%
Return on Equity (ROE)	18.72%	-41.02%	31.12%	49.84%	-117.17%	23.01%	13.64%	38.09%	-31.24%	-2.36%	-20.20%
Cash Return on Invested Capital (CROIC)	-7.06%	-16.09%	8.71%	-9.33%	152.10%	15.63%	-27.73%	19.78%	37.82%	13.48%	-2.01%
Operating Return on Assets (OROA)	7.55%	-2.25%	8.21%	10.80%	4.28%	5.21%	5.00%	3.77%	13.29%	11.02%	12.58%
Return on Assets (ROA)	3.65%	-4.59%	2.81%	5.31%	4.56%	-4.13%	-2.33%	-9.23%	9.49%	0.67%	4.66%
Return on Common Equity (ROCE)	14.41%	-28.05%	17.45%	29.96%	-225.27%	27.52%	17.36%	43.66%	-32.20%	-2.45%	-22.63%
Return on Equity Simple (ROE_SIMPLE)	30.42%	-96.27%	49.95%	70.92%	20.61%	18.35%	10.22%	29.80%	-32.32%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	60	-32	111	121	1,565	86	-256	40	342	30	159
NOPAT Margin	3.34%	-1.50%	4.29%	4.38%	63.09%	3.36%	-8.88%	1.30%	10.40%	0.88%	4.27%
Net Nonoperating Expense Percent (NNEP)	1.85%	5.72%	8.08%	3.05%	124.66%	12.31%	-15.16%	16.00%	11.51%	1.25%	4.59%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	2.99%	14.01%
Cost of Revenue to Revenue	43.27%	48.56%	49.36%	50.94%	50.33%	50.46%	51.70%	53.27%	51.49%	52.47%	53.71%
SG&A Expenses to Revenue	8.16%	9.72%	6.83%	5.91%	7.38%	7.60%	6.83%	6.79%	6.25%	6.42%	6.30%
R&D to Revenue	11.75%	11.39%	9.48%	8.61%	10.21%	9.82%	10.14%	9.81%	9.78%	9.82%	9.43%
Operating Expenses to Revenue	52.36%	53.58%	44.55%	43.11%	43.35%	44.74%	46.67%	44.87%	40.99%	40.88%	39.57%
Earnings before Interest and Taxes (EBIT)	104	-35	137	190	79	104	109	76	249	213	262
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	236	123	306	364	247	277	284	238	401	354	414
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.00	0.80	1.10	0.35	0.51	0.68	0.34	0.66
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	23.70	0.00	0.00	0.00	12.84	78.20	25.71
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	4.22%	0.00%	0.00%	0.00%	7.79%	1.28%	3.89%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	3.27	4.34	2.52	3.57	4.20	3.22	4.07
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	1.38	1.65	0.87	0.99	1.11	0.75	1.05
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	13.91	15.32	8.81	12.77	9.11	7.18	9.47
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	43.55	40.80	23.04	40.12	14.66	11.95	14.95
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	2.19	49.16	0.00	75.82	10.66	84.71	24.61
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	10.14	16.02	11.41	23.35	10.41	8.52	13.83
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	2.02	26.82	0.00	16.64	11.20	22.75	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.93	7.27	4.59	5.25	-4.24	-4.61	-4.64	-2.68	-3.05	-2.81	-4.05
Long-Term Debt to Equity	2.84	7.03	4.26	4.83	-4.18	-4.58	-4.61	-2.66	-3.02	-2.80	-4.01
Financial Leverage	1.85	4.00	5.31	4.72	-16.58	-3.83	-3.66	-2.90	-2.51	-2.52	-2.82
Leverage Ratio	5.13	8.93	11.08	9.39	-25.69	-5.58	-5.87	-4.12	-3.29	-3.54	-4.34
Compound Leverage Factor	3.25	20.04	5.38	6.27	-0.98	3.40	-0.50	1.64	-1.70	-1.61	-2.53
Debt to Total Capital	74.57%	87.90%	82.11%	84.00%	130.90%	127.73%	127.48%	159.62%	148.85%	155.14%	132.82%
Short-Term Debt to Total Capital	2.39%	2.90%	5.89%	6.67%	1.64%	0.73%	0.79%	1.04%	1.16%	0.89%	1.20%
Long-Term Debt to Total Capital	72.18%	85.00%	76.23%	77.33%	129.26%	127.00%	126.70%	158.58%	147.69%	154.25%	131.61%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	7.22%	4.57%	8.58%	5.19%	6.31%	5.21%	9.94%	1.11%	2.19%	1.96%	7.89%
Common Equity to Total Capital	18.21%	7.52%	9.30%	10.82%	-37.20%	-32.94%	-37.42%	-60.73%	-51.04%	-57.10%	-40.70%
Debt to EBITDA	2.87	7.12	2.70	2.81	5.81	6.28	5.93	6.88	4.00	4.48	3.89
Net Debt to EBITDA	2.51	6.92	2.56	2.72	5.63	4.89	4.78	6.15	3.48	3.82	3.29
Long-Term Debt to EBITDA	2.78	6.89	2.51	2.59	5.74	6.25	5.89	6.83	3.97	4.45	3.86
Debt to NOPAT	11.38	-27.40	7.43	8.49	0.92	20.15	-6.58	40.83	4.69	52.86	10.11
Net Debt to NOPAT	9.95	-26.60	7.03	8.20	0.89	15.69	-5.30	36.51	4.08	45.05	8.55
Long-Term Debt to NOPAT	11.01	-26.50	6.90	7.82	0.90	20.04	-6.54	40.56	4.65	52.55	10.02
Altman Z-Score	0.00	0.00	0.00	0.00	1.43	2.28	1.97	2.22	2.80	2.37	2.72
Noncontrolling Interest Sharing Ratio	23.01%	31.61%	43.91%	39.89%	-92.27%	-19.57%	-27.32%	-14.65%	-3.07%	-4.01%	-12.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.60	0.55	0.50	0.46	0.51	0.83	0.90	0.68	0.69	0.66	0.73
Quick Ratio	0.35	0.17	0.21	0.18	0.16	0.60	0.56	0.37	0.41	0.40	0.42
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-54	-142	83	-100	1,699	158	-274	183	326	112	-18
Operating Cash Flow to CapEx	231.70%	146.55%	190.63%	279.23%	364.64%	282.86%	247.79%	121.88%	391.13%	198.66%	175.92%
Free Cash Flow to Firm to Interest Expense	-1.42	-3.22	1.17	-1.58	22.40	0.95	-2.75	1.72	2.70	0.96	-0.16
Operating Cash Flow to Interest Expense	6.48	3.56	2.73	5.24	4.46	1.58	2.21	1.23	2.91	2.58	2.59
Operating Cash Flow Less CapEx to Interest Expense	3.68	1.13	1.30	3.36	3.24	1.02	1.32	0.22	2.17	1.28	1.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.29	1.36	1.56	1.56	1.35	1.29	1.33	1.53	1.76	1.76	1.79
Accounts Receivable Turnover	55.47	52.75	49.74	47.32	52.11	60.42	50.41	46.93	49.90	51.23	52.66
Inventory Turnover	42.41	32.06	23.88	22.08	17.05	17.31	15.17	13.99	16.55	17.02	16.07
Fixed Asset Turnover	3.72	4.25	5.21	5.65	5.98	7.72	9.38	10.72	11.91	11.99	11.16
Accounts Payable Turnover	10.14	9.69	9.15	8.30	7.16	7.15	5.81	5.47	5.54	5.42	6.03
Days Sales Outstanding (DSO)	6.58	6.92	7.34	7.71	7.00	6.04	7.24	7.78	7.31	7.13	6.93
Days Inventory Outstanding (DIO)	8.61	11.38	15.28	16.53	21.41	21.09	24.06	26.09	22.06	21.45	22.72
Days Payable Outstanding (DPO)	35.99	37.67	39.90	43.96	51.00	51.07	62.79	66.69	65.94	67.33	60.50
Cash Conversion Cycle (CCC)	-20.80	-19.37	-17.28	-19.72	-22.59	-23.93	-31.49	-32.82	-36.57	-38.75	-30.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	825	934	963	1,183	1,050	978	996	853	870	788	965
Invested Capital Turnover	2.33	2.43	2.73	2.56	2.22	2.54	2.93	3.33	3.82	4.11	4.26
Increase / (Decrease) in Invested Capital	114	110	29	221	-133	-72	17	-143	17	-82	177
Enterprise Value (EV)	0.00	0.00	0.00	0.00	3,433	4,250	2,506	3,042	3,649	2,541	3,923
Market Capitalization	0.00	0.00	0.00	0.00	1,976	2,822	1,016	1,566	2,230	1,169	2,464
Book Value per Share	$5.27	$2.41	$3.05	$4.29	($15.75)	($17.26)	($18.96)	($23.67)	($21.62)	($23.45)	($20.39)
Tangible Book Value per Share	($17.56)	($24.54)	($23.23)	($29.95)	($50.62)	($55.73)	($57.72)	($61.13)	($59.17)	($63.22)	($62.81)
Total Capital	910	997	1,007	1,219	1,095	1,364	1,323	1,026	1,078	1,022	1,214
Total Debt	679	877	827	1,024	1,434	1,742	1,686	1,638	1,604	1,585	1,612
Total Long-Term Debt	657	848	768	942	1,416	1,733	1,676	1,627	1,592	1,576	1,597
Net Debt	593	851	783	988	1,389	1,356	1,359	1,465	1,396	1,351	1,363
Capital Expenditures (CapEx)	107	107	101	119	93	94	89	107	90	150	161
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-199	-200	-227	-234	-265	-435	-383	-362	-402	-481	-445
Debt-free Net Working Capital (DFNWC)	-113	-175	-182	-199	-220	-100	-56	-194	-193	-247	-197
Net Working Capital (NWC)	-135	-203	-242	-280	-238	-110	-66	-204	-206	-256	-211
Net Nonoperating Expense (NNE)	9.23	40	64	27	1,481	169	-206	226	165	17	62
Net Nonoperating Obligations (NNO)	593	813	783	988	1,389	1,356	1,359	1,465	1,396	1,351	1,363
Total Depreciation and Amortization (D&A)	132	158	169	174	168	173	176	162	152	141	152
Debt-free, Cash-free Net Working Capital to Revenue	-11.11%	-9.38%	-8.74%	-8.52%	-10.70%	-16.89%	-13.26%	-11.77%	-12.21%	-14.13%	-11.92%
Debt-free Net Working Capital to Revenue	-6.34%	-8.17%	-7.04%	-7.24%	-8.88%	-3.87%	-1.93%	-6.29%	-5.88%	-7.26%	-5.26%
Net Working Capital to Revenue	-7.56%	-9.53%	-9.32%	-10.19%	-9.61%	-4.26%	-2.29%	-6.63%	-6.26%	-7.52%	-5.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.72	($2.29)	$1.41	$3.09	$3.07	($2.99)	($2.08)	($7.08)	$6.64	$0.60	$3.93
Adjusted Weighted Average Basic Shares Outstanding	31.66M	31.29M	30.95M	30.79M	27.18M	26.00M	26.09M	26.25M	26.15M	24.92M	24.43M
Adjusted Diluted Earnings per Share	$1.64	($2.29)	$1.36	$3.00	$3.00	($2.99)	($2.08)	$0.00	$6.43	$0.58	$3.79
Adjusted Weighted Average Diluted Shares Outstanding	33.05M	31.29M	32.22M	31.66M	27.77M	26.00M	26.09M	0.00	27.00M	25.64M	25.33M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$3.09	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	31.59M	31.30M	30.89M	30.39M	25.89M	25.05M	26.14M	26.36M	25.07M	24.48M	24.35M
Normalized Net Operating Profit after Tax (NOPAT)	83	-6.61	88	135	49	88	43	75	173	162	163
Normalized NOPAT Margin	4.67%	-0.31%	3.41%	4.90%	1.96%	3.40%	1.48%	2.42%	5.27%	4.77%	4.37%
Pre Tax Income Margin	3.70%	-3.71%	2.56%	4.61%	0.12%	-2.47%	0.32%	-0.98%	3.90%	2.85%	4.09%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.73	-0.80	1.94	3.01	1.04	0.62	1.09	0.72	2.07	1.84	2.40
NOPAT to Interest Expense	1.56	-0.73	1.58	1.91	20.64	0.52	-2.58	0.38	2.84	0.26	1.46
EBIT Less CapEx to Interest Expense	-0.06	-3.24	0.51	1.13	-0.18	0.06	0.20	-0.29	1.32	0.54	0.92
NOPAT Less CapEx to Interest Expense	-1.23	-3.16	0.15	0.03	19.42	-0.04	-3.47	-0.63	2.10	-1.04	-0.02
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-10.20%	0.00%	0.00%	3.61%	4.71%	-5.76%	-7.84%	-1.97%	0.31%	6.39%	0.00%
Augmented Payout Ratio	294.23%	-69.26%	204.87%	154.54%	751.25%	-11.90%	-12.12%	-53.43%	88.63%	643.12%	76.72%

This table displays calculated financial ratios and metrics derived from Cimpress' official financial filings.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026	6/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	24,285,192.00	24,232,090.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	24,285,192.00	24,232,090.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	0.57	1.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	9.01%	5.18%	5.55%	6.30%	1.93%	1.14%	4.43%	7.24%	10.97%	12.25%	8.68%
EBITDA Growth	156.53%	151.15%	-0.66%	-21.21%	1.00%	-9.99%	-23.73%	40.46%	-14.47%	36.32%	41.94%
EBIT Growth	562.84%	428.90%	7.42%	-31.27%	4.98%	-12.61%	-37.27%	88.26%	-20.25%	66.40%	66.29%
NOPAT Growth	258.26%	-338.58%	521.03%	124.31%	-28.44%	-110.55%	-158.54%	-52.40%	15.15%	134.65%	131.59%
Net Income Growth	143.49%	89.60%	331.64%	-371.04%	2.26%	-54.80%	-124.00%	152.65%	-19.68%	282.58%	193.31%
EPS Growth	140.07%	92.02%	284.68%	-394.12%	10.28%	-120.00%	-122.25%	160.00%	-17.37%	266.67%	204.21%
Operating Cash Flow Growth	115.65%	-33.11%	102.37%	-89.62%	0.90%	15.05%	-14.09%	471.60%	-6.72%	-270.42%	2.82%
Free Cash Flow Firm Growth	8.98%	-100.54%	21.17%	-107.56%	-92.73%	-10,025.04%	-125.69%	664.75%	596.25%	60.27%	-137.35%
Invested Capital Growth	-10.63%	-4.24%	1.96%	4.88%	6.06%	6.12%	-9.39%	-7.46%	-2.45%	9.05%	22.47%
Revenue Q/Q Growth	21.67%	-15.28%	6.66%	-3.32%	16.67%	-15.94%	10.14%	-0.71%	20.73%	-14.97%	6.63%
EBITDA Q/Q Growth	81.92%	-50.36%	39.28%	-37.36%	133.21%	-55.76%	18.02%	15.36%	42.00%	-29.49%	22.89%
EBIT Q/Q Growth	164.78%	-66.83%	84.17%	-57.51%	304.45%	-72.39%	32.20%	27.51%	71.34%	-42.39%	32.11%
NOPAT Q/Q Growth	585.91%	-144.47%	729.05%	-88.31%	118.84%	-230.83%	-74.91%	109.51%	429.40%	-60.63%	59.44%
Net Income Q/Q Growth	1,218.76%	-108.60%	2,380.76%	-110.48%	597.54%	-113.02%	-253.60%	122.99%	659.05%	-70.41%	80.71%
EPS Q/Q Growth	1,158.82%	-107.01%	2,946.67%	-111.71%	572.00%	-113.98%	-187.88%	131.58%	550.00%	-71.79%	80.00%
Operating Cash Flow Q/Q Growth	314.03%	-95.18%	1,384.45%	-96.50%	3,926.44%	-94.51%	1,008.53%	-76.68%	557.09%	-110.03%	768.85%
Free Cash Flow Firm Q/Q Growth	-5.45%	-100.72%	17,297.90%	-106.47%	190.94%	-1,099.82%	56.36%	242.33%	12.12%	-157.05%	-160.73%
Invested Capital Q/Q Growth	-8.56%	4.53%	6.36%	3.15%	-7.53%	4.59%	-9.19%	5.35%	-2.52%	16.93%	1.99%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.70%	48.16%	48.57%	47.48%	47.90%	47.18%	47.48%	46.66%	46.80%	46.17%	45.50%
EBITDA Margin	15.89%	9.31%	12.15%	7.88%	15.74%	8.28%	8.88%	10.31%	12.13%	10.06%	11.59%
Operating Margin	11.69%	5.03%	7.97%	4.89%	8.62%	5.14%	7.53%	5.67%	8.45%	5.55%	6.86%
EBIT Margin	11.64%	4.56%	7.87%	3.46%	11.99%	3.94%	4.73%	6.07%	8.62%	5.84%	7.24%
Profit (Net Income) Margin	6.54%	-0.66%	14.19%	-1.54%	6.56%	-1.02%	-3.26%	0.76%	4.75%	1.65%	2.80%
Tax Burden Percent	78.20%	-95.43%	355.10%	365.42%	74.44%	-194.47%	-210.72%	26.77%	78.77%	55.57%	67.24%
Interest Burden Percent	71.82%	15.26%	50.77%	-12.17%	73.49%	13.26%	32.73%	46.46%	69.94%	50.92%	57.56%
Effective Tax Rate	21.80%	195.43%	-255.10%	0.00%	25.56%	294.47%	310.72%	73.23%	21.23%	44.43%	32.76%
Return on Invested Capital (ROIC)	35.40%	-18.65%	108.14%	13.04%	26.74%	-39.90%	-65.13%	6.09%	28.97%	12.45%	19.66%
ROIC Less NNEP Spread (ROIC-NNEP)	33.69%	-16.46%	99.94%	10.29%	26.84%	-34.92%	-57.16%	5.62%	27.49%	11.54%	18.40%
Return on Net Nonoperating Assets (RNNOA)	-82.70%	38.06%	-251.15%	-25.98%	-67.12%	85.65%	144.07%	-14.46%	-70.04%	-32.68%	-51.92%
Return on Equity (ROE)	-47.29%	19.41%	-143.00%	-12.94%	-40.39%	45.75%	78.94%	-8.37%	-41.07%	-20.23%	-32.27%
Cash Return on Invested Capital (CROIC)	21.98%	22.58%	37.82%	36.51%	32.63%	30.86%	13.48%	14.71%	8.04%	0.59%	-2.01%
Operating Return on Assets (OROA)	19.17%	8.05%	13.83%	6.26%	20.83%	7.24%	8.34%	10.92%	15.31%	10.87%	12.96%
Return on Assets (ROA)	10.76%	-1.17%	24.94%	-2.78%	11.40%	-1.87%	-5.75%	1.36%	8.44%	3.08%	5.02%
Return on Common Equity (ROCE)	-48.40%	19.79%	-147.40%	-13.34%	-41.65%	47.08%	82.10%	-8.70%	-42.08%	-22.09%	-36.15%
Return on Equity Simple (ROE_SIMPLE)	-7.67%	-13.68%	0.00%	-28.17%	-29.26%	-28.59%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	84	-37	236	28	60	-79	-138	13	69	27	44
NOPAT Margin	9.14%	-4.80%	28.29%	3.42%	6.42%	-9.99%	-15.86%	1.52%	6.66%	3.08%	4.61%
Net Nonoperating Expense Percent (NNEP)	1.71%	-2.19%	8.21%	2.75%	-0.10%	-4.98%	-7.97%	0.47%	1.48%	0.90%	1.26%
Return On Investment Capital (ROIC_SIMPLE)	7.94%	-	-	-	5.82%	-7.65%	-13.75%	1.30%	6.54%	2.57%	3.83%
Cost of Revenue to Revenue	50.30%	51.84%	51.43%	52.52%	52.10%	52.82%	52.52%	53.34%	53.20%	53.83%	54.50%
SG&A Expenses to Revenue	5.30%	6.95%	6.53%	6.45%	6.06%	6.40%	6.80%	6.25%	5.78%	6.65%	6.58%
R&D to Revenue	8.68%	10.73%	10.08%	10.17%	8.82%	10.53%	9.91%	9.83%	8.55%	9.80%	9.70%
Operating Expenses to Revenue	38.02%	43.13%	40.61%	42.60%	39.29%	42.05%	39.95%	40.99%	38.34%	40.63%	38.65%
Earnings before Interest and Taxes (EBIT)	107	36	66	28	113	31	41	52	90	52	68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	146	73	101	63	148	65	77	89	126	89	110
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.66	0.73	0.68	0.61	0.54	0.33	0.34	0.45	0.46	0.48	0.66
Price to Earnings (P/E)	50.53	26.95	12.84	13.11	11.31	7.23	78.20	43.92	70.13	38.96	25.71
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.98%	3.71%	7.79%	7.63%	8.84%	13.83%	1.28%	2.28%	1.43%	2.57%	3.89%
Enterprise Value to Invested Capital (EV/IC)	4.43	4.66	4.20	3.93	3.84	2.94	3.22	3.55	3.69	3.43	4.07
Enterprise Value to Revenue (EV/Rev)	1.08	1.17	1.11	1.05	0.95	0.76	0.75	0.85	0.84	0.89	1.05
Enterprise Value to EBITDA (EV/EBITDA)	9.68	9.50	9.11	9.18	8.28	6.74	7.18	7.76	8.33	8.49	9.47
Enterprise Value to EBIT (EV/EBIT)	17.49	15.59	14.66	14.90	13.19	10.74	11.95	12.41	13.91	13.79	14.95
Enterprise Value to NOPAT (EV/NOPAT)	38.88	25.00	10.66	9.74	10.27	8.22	84.71	49.02	65.49	38.69	24.61
Enterprise Value to Operating Cash Flow (EV/OCF)	11.88	13.26	10.41	11.26	10.14	8.07	8.52	9.24	9.72	11.55	13.83
Enterprise Value to Free Cash Flow (EV/FCFF)	19.02	20.20	11.20	11.01	12.13	9.80	22.75	23.19	45.28	610.76	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-2.99	-2.57	-3.05	-2.92	-2.97	-2.96	-2.81	-2.87	-3.04	-3.50	-4.05
Long-Term Debt to Equity	-2.97	-2.55	-3.02	-2.90	-2.95	-2.94	-2.80	-2.85	-3.01	-3.47	-4.01
Financial Leverage	-2.45	-2.31	-2.51	-2.52	-2.50	-2.45	-2.52	-2.57	-2.55	-2.83	-2.82
Leverage Ratio	-3.42	-2.89	-3.29	-3.21	-3.60	-3.16	-3.54	-3.50	-3.79	-3.97	-4.34
Compound Leverage Factor	-2.46	-0.44	-1.67	0.39	-2.65	-0.42	-1.16	-1.63	-2.65	-2.02	-2.50
Debt to Total Capital	150.17%	163.70%	148.85%	152.03%	150.76%	151.09%	155.14%	153.60%	149.10%	139.99%	132.82%
Short-Term Debt to Total Capital	1.03%	1.12%	1.16%	1.00%	0.91%	0.87%	0.89%	0.87%	1.27%	1.22%	1.20%
Long-Term Debt to Total Capital	149.13%	162.59%	147.69%	151.03%	149.85%	150.22%	154.25%	152.73%	147.83%	138.77%	131.61%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	1.31%	1.30%	2.19%	2.35%	1.85%	1.98%	1.96%	1.84%	0.63%	6.19%	7.89%
Common Equity to Total Capital	-51.47%	-65.01%	-51.04%	-54.39%	-52.61%	-53.07%	-57.10%	-55.43%	-49.73%	-46.17%	-40.70%
Debt to EBITDA	4.51	3.99	4.00	4.16	4.13	4.20	4.48	4.17	4.44	4.16	3.89
Net Debt to EBITDA	3.69	3.59	3.48	3.76	3.54	3.72	3.82	3.64	3.72	3.67	3.29
Long-Term Debt to EBITDA	4.48	3.96	3.97	4.13	4.10	4.18	4.45	4.15	4.41	4.13	3.86
Debt to NOPAT	18.10	10.50	4.69	4.41	5.12	5.12	52.86	26.35	34.94	18.96	10.11
Net Debt to NOPAT	14.82	9.45	4.08	3.99	4.40	4.53	45.05	23.01	29.27	16.70	8.55
Long-Term Debt to NOPAT	17.97	10.43	4.65	4.39	5.09	5.09	52.55	26.20	34.64	18.79	10.02
Altman Z-Score	2.48	2.51	2.48	2.36	2.44	2.17	2.08	2.22	2.24	2.33	2.43
Noncontrolling Interest Sharing Ratio	-2.33%	-1.99%	-3.07%	-3.14%	-3.12%	-2.89%	-4.01%	-3.97%	-2.48%	-9.19%	-12.04%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.82	0.70	0.69	0.64	0.68	0.65	0.66	0.65	0.68	0.68	0.73
Quick Ratio	0.50	0.36	0.41	0.34	0.39	0.37	0.40	0.37	0.40	0.36	0.42
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	177	-1.27	219	-14	13	-129	-56	80	90	-51	-133
Operating Cash Flow to CapEx	700.20%	33.61%	1,510.08%	14.61%	410.54%	23.97%	293.70%	58.52%	408.26%	-43.37%	276.09%
Free Cash Flow to Firm to Interest Expense	5.86	-0.04	6.78	-0.45	0.43	-4.78	-2.03	2.85	3.32	-2.02	-4.60
Operating Cash Flow to Interest Expense	5.79	0.28	3.88	0.14	5.91	0.36	3.89	0.89	6.10	-0.65	3.81
Operating Cash Flow Less CapEx to Interest Expense	4.96	-0.55	3.62	-0.82	4.47	-1.14	2.56	-0.63	4.61	-2.15	2.43
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.65	1.77	1.76	1.81	1.74	1.84	1.76	1.80	1.78	1.86	1.79
Accounts Receivable Turnover	48.03	46.76	49.90	46.82	55.00	49.06	51.23	45.40	55.06	52.75	52.66
Inventory Turnover	13.62	15.79	16.55	15.32	16.78	17.73	17.02	15.86	16.71	17.27	16.07
Fixed Asset Turnover	11.56	11.72	11.91	12.24	12.09	12.07	11.99	11.74	11.37	11.43	11.16
Accounts Payable Turnover	5.04	6.30	5.54	6.12	5.10	6.19	5.42	5.92	5.44	6.42	6.03
Days Sales Outstanding (DSO)	7.60	7.81	7.31	7.80	6.64	7.44	7.13	8.04	6.63	6.92	6.93
Days Inventory Outstanding (DIO)	26.80	23.11	22.06	23.83	21.75	20.59	21.45	23.01	21.85	21.14	22.72
Days Payable Outstanding (DPO)	72.42	57.93	65.94	59.65	71.64	58.99	67.33	61.62	67.11	56.88	60.50
Cash Conversion Cycle (CCC)	-38.02	-27.01	-36.57	-28.03	-43.25	-30.97	-38.75	-30.57	-38.64	-28.82	-30.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	782	818	870	897	829	868	788	830	809	946	965
Invested Capital Turnover	3.87	3.89	3.82	3.81	4.17	4.00	4.11	4.01	4.35	4.04	4.26
Increase / (Decrease) in Invested Capital	-93	-36	17	42	47	50	-82	-67	-20	79	177
Enterprise Value (EV)	3,463	3,811	3,649	3,521	3,188	2,548	2,541	2,945	2,983	3,243	3,923
Market Capitalization	2,129	2,358	2,230	2,053	1,804	1,123	1,169	1,543	1,643	1,773	2,464
Book Value per Share	($20.78)	($23.88)	($21.62)	($22.78)	($22.04)	($22.46)	($23.45)	($23.33)	($21.51)	($21.58)	($20.39)
Tangible Book Value per Share	($57.61)	($59.74)	($59.17)	($61.64)	($59.24)	($60.77)	($63.22)	($63.65)	($61.57)	($61.77)	($62.81)
Total Capital	1,074	978	1,078	1,050	1,054	1,051	1,022	1,031	1,067	1,135	1,214
Total Debt	1,612	1,602	1,604	1,596	1,589	1,587	1,585	1,583	1,591	1,589	1,612
Total Long-Term Debt	1,601	1,591	1,592	1,586	1,579	1,578	1,576	1,574	1,578	1,575	1,597
Net Debt	1,321	1,441	1,396	1,443	1,364	1,404	1,351	1,382	1,333	1,400	1,363
Capital Expenditures (CapEx)	25	25	8.28	30	43	40	37	43	40	38	40
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-410	-344	-402	-385	-447	-410	-481	-457	-509	-409	-445
Debt-free Net Working Capital (DFNWC)	-119	-183	-193	-232	-223	-227	-247	-256	-251	-220	-197
Net Working Capital (NWC)	-130	-194	-206	-242	-232	-236	-256	-265	-265	-234	-211
Net Nonoperating Expense (NNE)	24	-32	117	40	-1.35	-71	-110	6.59	20	13	17
Net Nonoperating Obligations (NNO)	1,321	1,441	1,396	1,443	1,364	1,404	1,351	1,382	1,333	1,400	1,363
Total Depreciation and Amortization (D&A)	39	37	36	36	35	34	36	37	37	37	41
Debt-free, Cash-free Net Working Capital to Revenue	-12.78%	-10.58%	-12.21%	-11.52%	-13.31%	-12.17%	-14.13%	-13.20%	-14.29%	-11.18%	-11.92%
Debt-free Net Working Capital to Revenue	-3.69%	-5.63%	-5.88%	-6.94%	-6.63%	-6.74%	-7.26%	-7.41%	-7.05%	-6.02%	-5.26%
Net Working Capital to Revenue	-4.04%	-5.96%	-6.26%	-7.25%	-6.91%	-7.01%	-7.52%	-7.67%	-7.43%	-6.40%	-5.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.18	($0.15)	$4.44	($0.50)	$2.45	($0.33)	($1.02)	$0.31	$2.01	$0.57	$1.04
Adjusted Weighted Average Basic Shares Outstanding	26.61M	26.22M	26.15M	25.17M	24.97M	24.83M	24.92M	24.57M	24.57M	24.26M	24.43M
Adjusted Diluted Earnings per Share	$2.14	($0.15)	$4.27	($0.50)	$2.36	($0.33)	($0.95)	$0.30	$1.95	$0.55	$0.99
Adjusted Weighted Average Diluted Shares Outstanding	27.18M	26.22M	27.00M	25.17M	25.91M	24.83M	25.64M	25.05M	25.30M	25.19M	25.33M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	26.64M	25.45M	25.07M	25.15M	24.82M	24.88M	24.48M	24.67M	24.29M	24.23M	24.35M
Normalized Net Operating Profit after Tax (NOPAT)	85	28	47	28	60	29	49	34	70	29	45
Normalized NOPAT Margin	9.18%	3.53%	5.59%	3.43%	6.43%	3.64%	5.65%	4.00%	6.76%	3.26%	4.74%
Pre Tax Income Margin	8.36%	0.70%	4.00%	-0.42%	8.81%	0.52%	1.55%	2.82%	6.03%	2.97%	4.16%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.55	1.18	2.03	0.89	3.77	1.15	1.49	1.87	3.33	2.04	2.36
NOPAT to Interest Expense	2.78	-1.24	7.30	0.88	2.02	-2.92	-4.99	0.47	2.57	1.08	1.50
EBIT Less CapEx to Interest Expense	2.72	0.35	1.77	-0.07	2.33	-0.35	0.16	0.34	1.83	0.54	0.98
NOPAT Less CapEx to Interest Expense	1.96	-2.07	7.04	-0.08	0.58	-4.42	-6.31	-1.06	1.08	-0.42	0.12
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.30%	0.63%	0.31%	0.51%	0.51%	0.52%	6.39%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.30%	116.46%	88.63%	104.75%	132.49%	74.08%	643.12%	232.83%	385.14%	225.43%	76.72%

Financials Breakdown Chart

Key Financial Trends

Cimpress (NASDAQ:CMPR) shows a meaningful earnings recovery, but the balance sheet remains highly leveraged. Revenue reached $945.0 million in Q4 2026, up 8.7% from $869.5 million in Q4 2025 and about 44% above Q3 2022. However, profitability has not expanded at the same pace because cost of revenue and operating expenses remain elevated.

Revenue growth remains intact. Quarterly revenue increased from $657.4 million in Q3 2022 to $945.0 million in Q4 2026. The latest quarter also produced the highest revenue in the supplied data.
Net income improved sharply. Cimpress generated $26.5 million of consolidated net income in Q4 2026, compared with a $28.4 million loss in Q4 2025. For the four quarters of fiscal 2026, reported net income totaled approximately $97.1 million, versus roughly $12.8 million in the comparable fiscal 2025 periods.
Operating cash flow remains substantial. Q4 2026 operating cash flow was $110.5 million, following $164.7 million in Q2 and a $16.5 million outflow in Q3. Fiscal 2026 operating cash flow totaled approximately $283.8 million, providing funding for capital spending and debt service.
Share count has trended lower. Basic weighted-average shares declined from 26.2 million in Q3 2022 to 24.4 million in Q4 2026. Prior share repurchases likely supported per-share results, although the company issued a small amount of common equity in the latest quarter.
Capital spending is directed toward the operating business. Cimpress invested $42.7 million in property, plant and equipment during Q4 2026 and $20.7 million in acquisitions, suggesting continued investment in production capacity and growth initiatives.
Gross profit is growing in dollars but not in margin. Q4 gross profit rose to $430.0 million from $412.8 million a year earlier, while gross margin fell to approximately 45.5% from 47.5%. This indicates that revenue growth is being partially offset by higher production or fulfillment costs.
Operating income is relatively stable. Q4 operating income of $64.8 million was close to the $65.4 million recorded in Q4 2025. Marketing expense declined from $247.0 million in Q2 2026 to $205.7 million in Q4, but remained Cimpress’ largest operating expense.
Debt remains a significant financial risk. As of March 31, 2026, Cimpress reported $1.59 billion of long-term debt and $13.8 million of short-term debt, compared with $189.0 million of cash. Interest expense was $29.0 million in Q4 2026, and cash interest paid was $18.3 million.
Shareholders’ equity remains deeply negative. Total common equity was negative $524.1 million as of Q3 2026, largely reflecting $1.36 billion of treasury stock from historical repurchases. Negative equity reduces the balance sheet cushion available to shareholders and creditors.
Liquidity is constrained. At March 31, 2026, current assets totaled $495.8 million versus $730.0 million of current liabilities, implying a current ratio of approximately 0.68. Q4 cash generation was strong, but the company also repaid $115.6 million and issued $135.8 million of debt, highlighting its ongoing reliance on refinancing activity.

Overall, Cimpress’ recent trend is constructive on revenue, earnings and cash generation, particularly compared with the losses reported in parts of fiscal 2025 and 2024. Investors should nevertheless monitor gross margins, interest costs, working-capital swings and refinancing needs closely. The company’s high debt load and negative book equity make continued operating cash flow especially important.

08/17/26 01:36 PM ETAI Generated. May Contain Errors.

Cimpress Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Cimpress' financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Cimpress' net income appears to be on an upward trend, with a most recent value of $97.11 million in 2026, rising from $50.41 million in 2016. The previous period was $12.85 million in 2025. View Cimpress' forecast to see where analysts expect Cimpress to go next.

Cimpress' total operating income in 2026 was $251.03 million, based on the following breakdown:

Total Gross Profit: $1.73 billion
Total Operating Expenses: $1.48 billion

Over the last 10 years, Cimpress' total revenue changed from $1.79 billion in 2016 to $3.74 billion in 2026, a change of 109.0%.

Cimpress' total liabilities were at $2.60 billion at the end of 2026, a 2.7% increase from 2025, and a 111.0% increase since 2016.

In the past 10 years, Cimpress' cash and equivalents has ranged from $25.70 million in 2017 to $277.05 million in 2022, and is currently $248.85 million as of their latest financial filing in 2026.

Over the last 10 years, Cimpress' book value per share changed from 5.27 in 2016 to -20.39 in 2026, a change of -487.1%.

Related Companies

Financial statements for NASDAQ:CMPR last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cimpress (CMPR) Financials

Financials Breakdown Chart

Key Financial Trends

Cimpress Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cimpress (CMPR) Financials

Annual Income Statements for Cimpress

Quarterly Income Statements for Cimpress

Annual Cash Flow Statements for Cimpress

Quarterly Cash Flow Statements for Cimpress

Annual Balance Sheets for Cimpress

Quarterly Balance Sheets for Cimpress

Annual Metrics And Ratios for Cimpress

Quarterly Metrics And Ratios for Cimpress

Financials Breakdown Chart

Key Financial Trends

Cimpress Financials - Frequently Asked Questions

When does Cimpress' fiscal year end?

How has Cimpress' net income changed over the last 10 years?

What is Cimpress' operating income?

How has Cimpress' revenue changed over the last 10 years?

How much debt does Cimpress have?

How much cash does Cimpress have?

How has Cimpress' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools